BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31169592)

  • 1. Performing clinical 18F-FDG-PET/MRI of the mediastinum optimising a dedicated, patient-friendly protocol.
    Peerlings J; Paulis L; Mitea C; Bakers F; Berbée M; Wierts R; Vöö S; Wildberger J; Hoffmann A; Lambin P; Mottaghy F
    Nucl Med Commun; 2019 Aug; 40(8):815-826. PubMed ID: 31169592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.
    Schaarschmidt B; Buchbender C; Gomez B; Rubbert C; Hild F; Köhler J; Grueneisen J; Reis H; Ruhlmann V; Wetter A; Quick HH; Antoch G; Heusch P
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1257-67. PubMed ID: 25852011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold.
    Schwenzer NF; Seith F; Gatidis S; Brendle C; Schmidt H; Pfannenberg CA; laFougère C; Nikolaou K; Schraml C
    Korean J Radiol; 2016; 17(5):684-94. PubMed ID: 27587957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Im HJ; Paeng JC; Cheon GJ; Kim EE; Lee JS; Goo JM; Kang KW; Chung JK; Lee DS
    Nucl Med Commun; 2016 Jun; 37(6):616-22. PubMed ID: 26836629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Comparison of Misregistration in Abdominal and Pelvic Organs Between PET/MRI and PET/CT: Effect of Mode of Acquisition and Type of Sequence on Different Organs.
    Roy P; Lee JK; Sheikh A; Lin W
    AJR Am J Roentgenol; 2015 Dec; 205(6):1295-305. PubMed ID: 26587937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
    Grueneisen J; Sawicki LM; Wetter A; Kirchner J; Kinner S; Aktas B; Forsting M; Ruhlmann V; Umutlu L
    Eur J Radiol; 2017 Apr; 89():14-19. PubMed ID: 28267530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional fat-saturated T1-weighted Cartesian volumetric interpolated breath-hold examination (VIBE) for the diagnosis of aortitis in patients with suspected large vessel vasculitis: a comparative study with
    Einspieler I; Henninger M; Mergen V; Wendorff H; Haller B; Eiber M; Rummeny EJ; Schwaiger M; Moog P; Thürmel K
    Clin Radiol; 2019 Sep; 74(9):731.e11-731.e19. PubMed ID: 31130228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading.
    Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Beiderwellen K; Ruhlmann V; Umutlu L; Quick HH; Antoch G; Buchbender C
    Eur J Radiol; 2015 Jul; 84(7):1285-92. PubMed ID: 25975895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?
    Lee KH; Park CM; Lee SM; Lee JM; Cho JY; Paeng JC; Ahn SY; Goo JM
    PLoS One; 2015; 10(6):e0129660. PubMed ID: 26065695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
    Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.
    Nensa F; Tezgah E; Poeppel TD; Jensen CJ; Schelhorn J; Köhler J; Heusch P; Bruder O; Schlosser T; Nassenstein K
    J Nucl Med; 2015 Feb; 56(2):255-60. PubMed ID: 25552667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.